Data | Hora | Fonte | Título | Código | Companhia |
22/08/2012 | 13:02 | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
21/08/2012 | 07:00 | Zacks | Spectrum Extends Allos Buyout Offer - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
20/08/2012 | 07:02 | Edgar (US Regulatory) | Amended tender offer statement by Third Party (SC TO-T/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
20/08/2012 | 07:02 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (SC 14D9/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
17/08/2012 | 18:32 | Business Wire | Spectrum Pharmaceuticals & Allos Therapeutics Announce Additional Extension of Tender Offer Period for Shares of Allos Therap... | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
17/08/2012 | 17:18 | Edgar (US Regulatory) | Amended Quarterly Report (10-Q/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
03/08/2012 | 10:01 | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
13/07/2012 | 17:41 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
09/07/2012 | 10:25 | Dow Jones News | US HOT STOCK FUTURES: HOT STOCKS TO WATCH | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
09/07/2012 | 08:03 | Dow Jones News | U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
27/06/2012 | 17:16 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
25/06/2012 | 06:30 | Zacks | Spectrum Extends Allos Tender Offer - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
22/05/2012 | 17:51 | Edgar (US Regulatory) | Amended Statement of Changes in Beneficial Ownership (4/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
10/05/2012 | 08:00 | Business Wire | Spectrum Pharmaceuticals & Allos Therapeutics Announce Extension of Previously Announced Tender Offer For Shares of Allos The... | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
07/05/2012 | 06:45 | Zacks | Allos Narrows Loss, Awaits Takeover - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
01/05/2012 | 19:57 | Business Wire | Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Allos Therapeutics, Inc. | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
27/04/2012 | 17:18 | Edgar (US Regulatory) | Amended Annual Report (10-K/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
23/04/2012 | 14:45 | Zacks | Bad News for Allos - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
20/04/2012 | 10:54 | Business Wire | Allos Therapeutics Announces Outcome of Request for Re-examination of CHMP Opinion for FOLOTYN® in Europe | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
16/04/2012 | 17:59 | Edgar (US Regulatory) | Statement of Beneficial Ownership (SC 13D) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
16/04/2012 | 09:15 | Business Wire | Spectrum Pharmaceuticals Commences Tender Offer for All Outstanding Shares of Allos Therapeutics | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
16/04/2012 | 07:04 | Edgar (US Regulatory) | Statement of Ownership: Solicitation (SC 14D9) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
16/04/2012 | 07:04 | Edgar (US Regulatory) | Tender offer statement by Third Party (SC TO-T) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
13/04/2012 | 18:11 | Edgar (US Regulatory) | Amended Annual Statement of Changes in Beneficial Ownership (5/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
09/04/2012 | 12:26 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
09/04/2012 | 09:15 | Zacks | Allos Eyed by Spectrum Pharma - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
09/04/2012 | 06:06 | Zacks | Company News for April 9, 2012 - Corporate Summary | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
06/04/2012 | 07:07 | Edgar (US Regulatory) | Written communication by the subject company relating to a third party tender offer (SC14D9C) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
05/04/2012 | 18:23 | Edgar (US Regulatory) | Written communication relating to an issuer or third party (SC TO-C) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
05/04/2012 | 15:07 | Dow Jones News | UPDATE: Amid Setback, Spectrum Pharma To Buy Allos For $206 Million | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |